Qube Research & Technologies (QRT)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-45,052
Closed -$810K 2286
2020
Q2
$810K Buy
+45,052
New +$627K 0.01% 930
2020
Q1
Sell
-14,023
Closed -$335K 1883
2019
Q4
$335K Buy
+14,023
New +$387K 0.01% 1169

Qube Research & Technologies (QRT)'s PTLA Position: Q3 2020 in Review

Qube Research & Technologies (QRT) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 45,052 shares — an estimated $810K sold.

Qube Research & Technologies (QRT) first reported a position in PTLA in Q4 2019 and held it in 2 quarters. The position peaked at $810K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Qube Research & Technologies (QRT) reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 45,052 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $810K.
  • Qube Research & Technologies (QRT) first reported a position in Portola Pharmaceuticals, Inc. in Q4 2019 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Portola Pharmaceuticals, Inc. position peaked at $810K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2020, filed 12 Nov 2020.